Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,165 total articles
Gershon M. Distenfeld, a vice president at AllianceBernstein Global High Income Fund Inc., sold 5,462 shares of AWF on February 5, 2026, for $57,733 at $10.57 per share. Earlier, on January 22, 2026, he bought 1,593 shares across two transactions at prices between $10.595 and $10.599 totaling $16,880. After these trades he directly owns 14,801.2209…
Roger E. Susi, the chief executive, president, and chairman of Iradimed Corporation (NASDAQ: IRMD), sold 7,490 shares of common stock on April 6 and 7, 2026, in transactions totaling $717,207. The trades were carried out under a 10b5-1 plan established on November 5, 2025, and executed indirectly through the Phillip Susi 2008 Dynasty Trust. The com…
Robert E. Dixon, CEO and President of MacKenzie Realty Capital, Inc. (NASDAQ:MKZR), acquired 10,000 shares on April 6, 2026, a purchase totaling $34,972. The transaction was disclosed on a Form 4 filing with the SEC. The company has recently reorganized its multifamily assets into a new wholly owned entity and amended an equity distribution agreeme…
Mentor Capital CEO Chester Billingsley reported a purchase of 897 common shares at $0.063 per share on April 7, 2026, a transaction valued at approximately $56. The acquisition follows a sharp one-week decline in the stock and a recent conversion of Series Q preferred shares into common shares. Separately, Mentor Capital disclosed a change in its i…
Mark Casper, Executive Vice President and Chief Legal Officer at Marvell Technology, executed a sale of 6,900 shares of the company's common stock on April 6, 2026, generating proceeds of $755,205. The transaction leaves Casper with 4,023 shares held directly and an additional 10,263 shares held indirectly in trust. The disclosure arrives as Marvel…
James R. Reske, Executive Vice President and Chief Financial Officer of First Commonwealth Financial Corp (FCF), sold 2,072 shares of the bank's common stock on April 6, 2026, under a trading plan adopted in March 2025. The transactions generated $37,006 in proceeds at prices between $17.81 and $17.905. Reske continues to own 83,420 shares outright…
Margaret L. Jenkins, a director at Citi Trends Inc (NASDAQ: CTRN), sold 2,000 shares on April 6, 2026, for $45.91 per share, generating $91,820. The transaction follows a 139% one-year gain for the stock, though the current market price of $44.96 is below Jenkins' sale price. The company recently reported a Q4 2025 earnings beat and multiple analys…
Murray Stahl, President and Co-Portfolio Manager at RENN Fund, Inc. (RCG), purchased 1,134 shares of common stock on April 6, 2026, at $3.05 per share, for a total of $3,458. The transaction added to both his direct and indirect holdings as the stock sits close to its 52-week high and has returned 37% over the past year.
Darden Restaurants Group President Melvin John Martin sold 5,091 shares on April 6, 2026, for roughly $998,040 after exercising options to acquire the same number of shares. The transaction follows a fiscal third-quarter outperformance and a series of analyst price-target increases for Darden Restaurants Inc (DRI).
Teradyne director Johnson Mercedes sold 625 shares of TERADYNE, INC (NASDAQ:TER) common stock on April 6, 2026, for $312.20 per share, a transaction totaling $195,125. The sale was executed under a Rule 10b5-1 plan adopted in February 2025. Following the trade Mercedes retains direct ownership of 6,363 shares and indirect ownership of 1,876 shares …
Mari Steinmetz, Senior Executive Vice President and Chief People Officer at Kohl’s Corp (KSS), executed an automatic sale of 112 shares on April 6, 2026, under a Rule 10b5-1 plan. The trade, valued at $1,453, leaves her with 244,338 shares, including 220,294 unvested restricted stock units. Kohl’s recent fourth-quarter 2025 results showed an EPS be…
InterDigital Chief Technology Officer Rajesh Pankaj sold 1,500 shares on April 6, 2026, for $313.30 each, netting $469,950. The transaction occurred as the stock traded near $314 after a 62% year-over-year rise. The company also declared a quarterly dividend, announced patent licensing agreements and won a preliminary injunction in Brazil related t…
Chris Koopmans, Marvell Technology's President and COO, sold 10,000 shares on April 6, 2026, for about $1.1 million under a 10b5-1 plan. The transaction, disclosed in a Form 4 filing, occurred as Marvell's shares approached a 52-week high amid significant analyst attention tied to a strategic investment and partnership with Nvidia.
Edward S. Lampert, a 10% shareholder in Lands' End, completed a sale of 1,300,505 shares on April 1, 2026, for $45.00 per share, yielding $58,522,725, according to a Form 4 filing with the SEC. The transaction leaves Lampert with 15,813,925 shares directly held. Lands' End's latest quarterly results missed analyst estimates for both earnings and re…
Amir F Heshmatpour, president of NeonC Technologies Holdings, Inc. (NASDAQ:NTHI), purchased 25,000 shares of the company's common stock in two transactions totaling $153,398, according to a Form 4 filing. The purchases occurred on April 2 and April 6, 2026, while the stock traded below recent highs. Separately, the company disclosed a private place…
Daniel J. Lippis, CVP of TAVR at Edwards Lifesciences (NYSE:EW), sold 1,019 shares on April 6, 2026 for $82,522 and exercised options to acquire the same number of shares at $59.2567 per share. The transactions were made under a Rule 10b5-1 trading plan adopted July 30, 2025. Edwards reported mixed fourth-quarter results and announced positive two-…
Penumbra Inc. director Grewal Harpreet sold 100 shares on April 2, 2026, for $32,822 under a Rule 10b5-1 plan. The transaction follows a 32% rally over six months and comes as the company reported stronger-than-expected fourth-quarter 2025 results and announced a proposed acquisition by Boston Scientific valued at $374 per share.
Gagan Jain, Vice President of Worldwide Sales at Power Integrations Inc. (POWI), reported a sale of 313 shares on April 2, 2026, executed to satisfy tax obligations tied to a vested Restricted Stock Award. The trade, disclosed in a Form 4 filing with the SEC, amounted to $16,253. The stock has risen roughly 45% year-to-date and sits near $51.44 wit…
Director Higuchi John W. bought 123,000 shares of Lipocine Inc. (NASDAQ: LPCN) on April 6, 2026, for $2.05 per share, a transaction totaling $252,149. The purchase brings his direct holdings to 163,797 shares. The transaction coincides with the stock trading close to a 52-week low, and follows Phase 3 trial results for LPCN 1154 that missed the pri…
John W. Schlosser, Vice President and President, Terminals at Kinder Morgan, sold 6,166 shares of Class P common stock on April 6, 2026, for roughly $203,071 under a pre-established 10b5-1 plan. The disposal occurred while KMI shares trade near a 52-week high and amid a patchwork of recent analyst revisions and corporate pipeline developments.
RA Capital Management and affiliated parties sold a combined 842,282 shares of Vor Biopharma Inc. (NASDAQ: VOR) in multiple transactions on April 2 and April 6, 2026, generating proceeds of about $14.5 million. The disposals took place as VOR's share price traded with notable volatility and followed a period of fresh financing and clinical mileston…
Magnetar Financial LLC, a roughly 10% holder of Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR), sold a total of 23,088 shares of Wheeler common stock between April 1 and April 6, 2026, for approximately $21,460. The trades came in three blocks at weighted average prices from $0.9234 to $0.9466 per share. Wheeler continues to adjust its c…
Lipocine Inc. (NASDAQ:LPCN) Chief Executive Officer Mahesh V. Patel purchased 25,000 shares of company stock on April 6, 2026 at $2.03 per share, totaling $50,749. The transaction occurs as the share price trades close to a 52-week low of $1.81 after a 74% decline over the prior week. Separately, Lipocine disclosed that its postpartum depression dr…
Arve Hanstveit, a director at Energy Recovery, Inc. (NASDAQ: ERII), sold 165,292 shares on April 2, 2026, for roughly $1.67 million at $10.14 per share. The disposition was executed by a broker without Hanstveit's instruction to satisfy a margin call on shares pledged as collateral. The transaction comes as Energy Recovery reported fourth-quarter 2…
Paul L. Alpern, Vice President and General Counsel of Arteris, Inc. (NASDAQ: AIP), sold 3,649 shares of common stock on April 2, 2026, in transactions executed at $17.6528 per share, totaling $64,415. The disposals were carried out to satisfy tax obligations tied to the release of restricted stock units and were not described as discretionary trade…
